TechNews

Altruist Biologics’ Suzhou Site Receives EMA GMP Certification

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at

The company’s Quality Risk Management framework enabled proactive identification of compliance risks, reduced uncertainties associated with cross-regional technology transfer, and provided greater predictability as therapies advance toward regulatory submission and commercialization. The post…

devscience

Sources